Anil Kapur

Chief Commercial Officer, Actinium Pharmaceuticals, Inc.

Companies

Nurix (United States)Board member Oct 16, 2024 to now¹
Verastem OncologyBoard member Oct 24, 2022 to now²
Geron CorporationEVP, Corp Strategy & CCO Dec 4, 2019 to Jun 12, 2024³
Actinium Pharmaceuticals, Inc.Chief Commercial Officer Feb 8, 2018 to Jul 16, 2019⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Verastem Oncology VSTM52,666 shares⁵$484.3K at $9.20May 21, 2026
Geron Corporation GERN0 shares⁶Jun 10, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

May 21, 2026Granted 36,000 shares of Verastem Oncology⁵
May 22, 2025Granted 8,333 shares of Verastem Oncology⁷
Jun 18, 2024Granted 8,333 shares of Verastem Oncology⁸
Jun 10, 2024Sold 421,875 shares at $4.65 of Geron Corporation⁶
Jun 10, 2024Exercised options 421,875 shares at $1.06 of Geron Corporation⁶
Jun 30, 2023Granted 7,567 shares at $2.04 of Geron Corporation⁹
Dec 30, 2022Granted 6,021 shares at $1.11 of Geron Corporation¹⁰
Jun 30, 2022Granted 13,062 shares at $1.11 of Geron Corporation¹¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARNurix (United States), Board member
2
SEC EDGARVerastem Oncology, Board member
3
SEC EDGARGeron Corporation, EVP, Corp Strategy & CCO
4
SEC EDGARActinium Pharmaceuticals, Inc., Chief Commercial Officer
5
SEC EDGARVerastem Oncology shares after the filing of May 21, 2026
6
SEC EDGARGeron Corporation shares after the filing of Jun 10, 2024
7
SEC EDGARForm 4 filed May 27, 2025
8
SEC EDGARForm 4 filed Jun 20, 2024
9
SEC EDGARForm 4 filed Jun 30, 2023
10
SEC EDGARForm 4 filed Jan 3, 2023
11
SEC EDGARForm 4 filed Jul 1, 2022